CD47 blockade augmentation of trastuzumab antitumor efficacy dependent on antibody-dependent cellular phagocytosis. (Record no. 30275835)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02060 a2200589 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250518065835.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 202010s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 2379-3708 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1172/jci.insight.131882 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Tsao, Li-Chung |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20201015 |
| 245 00 - TITLE STATEMENT | |
| Title | CD47 blockade augmentation of trastuzumab antitumor efficacy dependent on antibody-dependent cellular phagocytosis. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | JCI insight |
| Date of publication, distribution, etc. | 12 2019 |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Animals |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antibody-Dependent Cell Cytotoxicity |
| General subdivision | drug effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antineoplastic Combined Chemotherapy Protocols |
| General subdivision | pharmacology |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Breast |
| General subdivision | pathology |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Breast Neoplasms |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | CD47 Antigen |
| General subdivision | antagonists & inhibitors |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Cell Line, Tumor |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Drug Synergism |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Female |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Immunity, Innate |
| General subdivision | drug effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Macrophages |
| General subdivision | drug effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Mice |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Phagocytosis |
| General subdivision | drug effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Prognosis |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Receptor, ErbB-2 |
| General subdivision | antagonists & inhibitors |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Trastuzumab |
| General subdivision | pharmacology |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Xenograft Model Antitumor Assays |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Crosby, Erika J |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Trotter, Timothy N |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Agarwal, Pankaj |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Hwang, Bin-Jin |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Acharya, Chaitanya |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Shuptrine, Casey W |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Wang, Tao |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Wei, Junping |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Yang, Xiao |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Lei, Gangjun |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Liu, Cong-Xiao |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Rabiola, Christopher A |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Chodosh, Lewis A |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Muller, William J |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Lyerly, Herbert Kim |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Hartman, Zachary C |
| 773 0# - HOST ITEM ENTRY | |
| Title | JCI insight |
| Related parts | vol. 4 |
| -- | no. 24 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1172/jci.insight.131882">https://doi.org/10.1172/jci.insight.131882</a> |
| Public note | Available from publisher's website |
No items available.